WeVote
Log In

Bill

Bill

SB 2437

Drugs, Prescription - As introduced, authorizes an owner or person in legal possession of drugs or devices deemed adulterated to request a show cause hearing electronically, rather than strictly in writing. - Amends TCA Title 47; Title 53; Title 56; Title 63 and Title 68.

114th Regular Session (2025-2026) Introduced by Brent Taylor

Allows electronic as well as written show-cause hearing requests for adulterated drugs/devices, preserving 10-day filing deadline and substantive standards.

Passed on Second Consideration, refer to Senate Commerce and Labor Committee
#drugs #prescription
0
WeVote Research Nonpartisan
Bill Summary · SB 2437

Bill Summary: SB 2437 (Session 114) — Tennessee

Title: Drugs, Prescription — As introduced, authorizes an owner or person in legal possession of drugs or devices deemed adulterated to request a show cause hearing electronically, rather than strictly in writing.
Jurisdiction: Tennessee

1) Purpose and Intent

  • The bill seeks to modify how an owner or person in legal possession of drugs or devices deemed adulterated can request a show-cause hearing.
  • Specifically, it allows this request to be made electronically, in addition to the existing written method.
  • The change is designed to streamline and modernize the process without altering the substantive treatment of adulterated drugs or devices under state law.

2) Key Provisions and Changes

  • Amends Tennessee Code Annotated (TCA), Title 53-10-106, subsection (d), by:
    • Replacing the requirement for a written show-cause hearing request with a method that permits electronic submission.
    • The owner or legal possessor must request a show-cause hearing within ten (10) days of receipt of the notice to show cause.
  • Other titles referenced (47, 53, 56, 63, 68) indicate broader alignment with how FDA-approved medications and related devices are regulated, but the core change is the method of hearing request (electronic allowed, in addition to written).

3) Who/What Is Affected

  • Affected Parties: Owners or persons in legal possession of drugs or devices deemed adulterated under the relevant Tennessee statutes.
  • Administrative Body: Tennessee Board referenced in the statute (the “board” in the show-cause process). The bill preserves the timing window (10 days) for filing the request.
  • No substantive change to the grounds for adulteration or the legal standards for adjudicating adulteration, only the filing method.

4) Procedural and Timeline Aspects

  • Filing Window: The requester must act within ten (10) days after receipt of the show-cause notice.
  • Method of Request: Electronic filing is now explicitly permitted as an option alongside traditional written submission.
  • Effective Date: The act takes effect upon becoming law, with the public welfare requiring it (immediate effect upon enactment).

5) Fiscal and Administrative Impact

  • Fiscal Impact: Not significant. The Fiscal Review Committee indicates no meaningful impact on state or local government operations.
  • Administrative Impact: Minor procedural modernization by enabling electronic submissions; no broad changes to substantive regulatory standards.

6) Additional Notes

  • Legislative History (Actions):
    • Introduced and passed First Consideration on 2026-02-02.
    • Passed Second Consideration on 2026-02-05 and referred to Senate Commerce and Labor Committee (per the action history).
  • Sponsor: Senate — Brent Taylor (Co-sponsor); House counterpart is HB 2173 by Travis.

Summary

SB 2437 modernizes the show-cause hearing request process for adulterated drugs or devices by explicitly allowing electronic submissions in addition to written requests, while preserving the 10-day filing deadline and the existing regulatory framework. The measure aims to improve efficiency without altering substantive law, with no significant fiscal impact anticipated.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.